JP2017513856A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017513856A5 JP2017513856A5 JP2016562948A JP2016562948A JP2017513856A5 JP 2017513856 A5 JP2017513856 A5 JP 2017513856A5 JP 2016562948 A JP2016562948 A JP 2016562948A JP 2016562948 A JP2016562948 A JP 2016562948A JP 2017513856 A5 JP2017513856 A5 JP 2017513856A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- pharmaceutical composition
- polypeptide
- acid peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 38
- 150000001413 amino acids Chemical class 0.000 claims 22
- 239000008194 pharmaceutical composition Substances 0.000 claims 18
- 229920001184 polypeptide Polymers 0.000 claims 18
- 102000004196 processed proteins & peptides Human genes 0.000 claims 18
- 125000003275 alpha amino acid group Chemical group 0.000 claims 13
- 239000012634 fragment Substances 0.000 claims 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 8
- 230000003779 hair growth Effects 0.000 claims 8
- 201000010099 disease Diseases 0.000 claims 4
- 208000035475 disorder Diseases 0.000 claims 4
- 230000002401 inhibitory effect Effects 0.000 claims 4
- 241000282412 Homo Species 0.000 claims 3
- 239000002671 adjuvant Substances 0.000 claims 3
- -1 carrier Substances 0.000 claims 3
- 239000003085 diluting agent Substances 0.000 claims 3
- 210000004209 hair Anatomy 0.000 claims 3
- 210000003780 hair follicle Anatomy 0.000 claims 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims 3
- 239000002537 cosmetic Substances 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 230000003054 hormonal effect Effects 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 201000010065 polycystic ovary syndrome Diseases 0.000 claims 2
- 206010000599 Acromegaly Diseases 0.000 claims 1
- 208000005676 Adrenogenital syndrome Diseases 0.000 claims 1
- 208000008448 Congenital adrenal hyperplasia Diseases 0.000 claims 1
- 102000018997 Growth Hormone Human genes 0.000 claims 1
- 108010051696 Growth Hormone Proteins 0.000 claims 1
- 206010020112 Hirsutism Diseases 0.000 claims 1
- 206010022489 Insulin Resistance Diseases 0.000 claims 1
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 1
- CXOFVDLJLONNDW-UHFFFAOYSA-N Phenytoin Chemical compound N1C(=O)NC(=O)C1(C=1C=CC=CC=1)C1=CC=CC=C1 CXOFVDLJLONNDW-UHFFFAOYSA-N 0.000 claims 1
- 208000010067 Pituitary ACTH Hypersecretion Diseases 0.000 claims 1
- 208000020627 Pituitary-dependent Cushing syndrome Diseases 0.000 claims 1
- 244000099172 Prunus ilicifolia subsp ilicifolia Species 0.000 claims 1
- 235000016794 Prunus ilicifolia subsp ilicifolia Nutrition 0.000 claims 1
- OXHNQTSIKGHVBH-ANULTFPQSA-N Tetrahydrogestrinone Chemical compound C1CC2=CC(=O)CCC2=C2[C@@H]1[C@@H]1CC[C@](CC)(O)[C@@]1(CC)C=C2 OXHNQTSIKGHVBH-ANULTFPQSA-N 0.000 claims 1
- 201000005188 adrenal gland cancer Diseases 0.000 claims 1
- 208000024447 adrenal gland neoplasm Diseases 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 201000008230 cutaneous porphyria Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000000122 growth hormone Substances 0.000 claims 1
- 206010020718 hyperplasia Diseases 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 229960003632 minoxidil Drugs 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 229960002036 phenytoin Drugs 0.000 claims 1
- 210000000130 stem cell Anatomy 0.000 claims 1
- 238000011200 topical administration Methods 0.000 claims 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1406989.2 | 2014-04-17 | ||
| GBGB1406989.2A GB201406989D0 (en) | 2014-04-17 | 2014-04-17 | Novel treatments |
| PCT/GB2015/051165 WO2015159099A1 (en) | 2014-04-17 | 2015-04-17 | Compositions comprising osteopontin derivatives for the inhibition of hair growth |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017513856A JP2017513856A (ja) | 2017-06-01 |
| JP2017513856A5 true JP2017513856A5 (cg-RX-API-DMAC7.html) | 2018-05-31 |
Family
ID=50928957
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016562948A Abandoned JP2017513856A (ja) | 2014-04-17 | 2015-04-17 | 毛成長抑制のためのオステオポンチン誘導体を含む組成物 |
Country Status (14)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102700014B1 (ko) * | 2017-05-04 | 2024-08-29 | 폴리쿰 에이비 | 당뇨병 치료용 펩타이드 |
| KR102091567B1 (ko) * | 2018-06-15 | 2020-03-20 | 인하대학교 산학협력단 | 오스테오폰틴 단백질 단편을 유효성분으로 함유하는 뇌손상 예방 또는 치료용 약학 조성물 |
| CN113164548A (zh) * | 2018-11-07 | 2021-07-23 | 富力卡姆股份公司 | 用于治疗糖尿病的肽片段 |
| WO2020161255A1 (en) * | 2019-02-07 | 2020-08-13 | Dsm Ip Assets B.V. | Novel method for reducing hair growth |
| EP3692978A1 (en) * | 2019-02-07 | 2020-08-12 | DSM IP Assets B.V. | Novel method |
| EP3958835B1 (en) * | 2019-04-24 | 2023-05-24 | Follicum AB | Topical formulation |
| IL300592A (en) | 2020-02-25 | 2023-04-01 | Amplifica Inc | Preparations and methods to stimulate hair growth |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5753612A (en) * | 1992-10-27 | 1998-05-19 | Yissum Research Development Co. Of The Hebrew University Of Jerusalem | Pharmaceutical composition and method for inhibiting hair growth by administration of activin or activin agonists |
| US6884772B1 (en) * | 1999-10-21 | 2005-04-26 | Kao Corporation | Depilatories and agents for external use |
| US7504232B2 (en) * | 2000-03-23 | 2009-03-17 | Smithkline Beecham Corporation | Method of screening for inhibitors of osteopontin |
| WO2008086449A2 (en) * | 2007-01-09 | 2008-07-17 | Oregon Health & Science University | Synthetic osteopontin peptides and methods of use |
| GB2493540A (en) * | 2011-08-10 | 2013-02-13 | Follicum Ab | Agents for stimulating hair growth in mammals |
-
2014
- 2014-04-17 GB GBGB1406989.2A patent/GB201406989D0/en not_active Ceased
-
2015
- 2015-04-17 BR BR112016023899A patent/BR112016023899A2/pt not_active Application Discontinuation
- 2015-04-17 CA CA2945930A patent/CA2945930A1/en not_active Abandoned
- 2015-04-17 SG SG11201608497YA patent/SG11201608497YA/en unknown
- 2015-04-17 KR KR1020167027851A patent/KR20160136342A/ko not_active Withdrawn
- 2015-04-17 AU AU2015248652A patent/AU2015248652A1/en not_active Abandoned
- 2015-04-17 EP EP15721789.4A patent/EP3131528A1/en not_active Withdrawn
- 2015-04-17 US US15/300,056 patent/US20170143605A1/en not_active Abandoned
- 2015-04-17 MX MX2016013589A patent/MX2016013589A/es unknown
- 2015-04-17 JP JP2016562948A patent/JP2017513856A/ja not_active Abandoned
- 2015-04-17 CN CN201580019288.XA patent/CN106413734A/zh active Pending
- 2015-04-17 RU RU2016144971A patent/RU2016144971A/ru not_active Application Discontinuation
- 2015-04-17 WO PCT/GB2015/051165 patent/WO2015159099A1/en not_active Ceased
-
2016
- 2016-09-27 IL IL248084A patent/IL248084A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017513856A5 (cg-RX-API-DMAC7.html) | ||
| RU2014108819A (ru) | Новые композиции и их применение | |
| HUE035584T2 (en) | A therapeutic agent for the treatment of allopathy | |
| CN107921106A (zh) | Wt1抗原肽和免疫调节剂的组合 | |
| CA2596597A1 (en) | Method for stimulation collagen synthesis and/or kgf expression | |
| RU2016144971A (ru) | Композиции, содержащие производные остеопонтина для ингибирования роста волос | |
| CN107973838A (zh) | 一种促进皮肤损伤修复的小分子多肽及其应用 | |
| JPWO2019156137A5 (cg-RX-API-DMAC7.html) | ||
| CN114949171A (zh) | 血管生成性疾病的免疫疗法 | |
| Rekers et al. | Stereotactic ablative body radiotherapy combined with immunotherapy: present status and future perspectives | |
| JP2017504589A5 (cg-RX-API-DMAC7.html) | ||
| EP4349360A3 (en) | Peptide exhibiting wrinkle-improving activity and uses thereof | |
| WO2020018315A3 (en) | Oral anti-inflammatory peptides to treat epilepsy, seizures and cns disorders | |
| US20200347096A1 (en) | Cyclic peptide and a medicament, external preparation and cosmetic comprising said cyclic peptide | |
| CN106581641A (zh) | 一种多肽在预防或治疗心肌缺血再灌注损伤相关疾病中的药物应用 | |
| Long et al. | Role of hypoxia-induced VEGF in blood-spinal cord barrier disruption in chronic spinal cord injury | |
| KR20160050173A (ko) | 신규 펩타이드 및 성장인자 콤플렉스를 함유한 상처 재생 및 피부 진정용 화장료 조성물 | |
| WO2011159758A4 (en) | Long lasting drug formulations | |
| JP2018528259A5 (cg-RX-API-DMAC7.html) | ||
| ES2393125T3 (es) | Un método para estimular la angiogénesis usando DKK2 y composición que comprende la misma | |
| RU2017126212A (ru) | Композиция | |
| WO2007136225A1 (en) | A method for inhibiting angiogenesis using dkk1 and composition comprising the same | |
| CN106572956B (zh) | 含有趋化因子的皮肤美白用组合物 | |
| CA2755897A1 (en) | Treatment of cancers with immunostimulatory hiv tat derivative polypeptides | |
| JP2008531463A5 (cg-RX-API-DMAC7.html) |